Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Rosiglitazone on Bone Marrow and Bone Cells
NCT00609362Phase 2Completed
- Sponsor
- Aarhus University
- Start
- Jan 2008
- Primary completion
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of rosiglitazone in type 2 diabetes mellitus (T2DM), sponsored by Aarhus University. Started Jan 2008; status: completed.
02
Drugs
rosiglitazone
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00609362.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00609362.